Fingerprint
Dive into the research topics of 'Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes
Stuart E. Samuels, Matthew H. Stenmark, Jae Y. Lee, Jonathan B. McHugh, James A. Hayman, Mark B. Orringer, Susan G. Urba, Libin Sun, Congying Xie, Feng Ming Kong, Kyle C. Cuneo
Research output: Contribution to journal › Article › peer-review